This report describes the modifications by a benign virus infection (1) (2) (3) (4) (5) of certain elements of the immune apparatus of mice. The data demonstrate that a persisting benign virus infection is capable of impairing the reproduction, or activation, of antibody-forming cells (AFC). In contrast, a significant but ephemeral stimulation of AFC was associated with the early acute phase of infection by the lactate dehydrogenase-elevating virus (LDH-virus).
These influences on AFC are coupled, by inference, to the more general effects of the LDH-virus in potentiating certain types of oncogenesis (6) . The short-term stimulation of AFC by the LDH-virus in its acute stage may explain the immunological adjuvant effects ascribed to the virus under some circumstances (6) (7) (8) . Two other effects induced by the virus are relevant to oncogenic and immunological studies. One involves the potentiation of cancer therapy when certain enzymes are used; the other promotes malignant processes.
The presence of the LDH-virus greatly enhances asparaginase (EC 3.5.1.1; L-asparagine amidohydrolase) therapy in mice (9) (10) (11) (12) 36) . Although several contributing factors are involved in this therapeutic phenomenon (13) (14) (15) , an important effect appears to be the delayed appearance of effective anti--bodies against the administered asparaginase. This enzyme has potent antileukemic properties but generates an undesirable neutralizing immunological response in the recipient, either mouse or patient, as expected for any foreign protein (14, 15) . The data reported here provide a reasonable explanation for an impairment of antibody production by a long-term suppression of B-cell activity by the chronic viral infection, and thus by inference, a delay or reduction in humoral antibody production against asparaginase.
This capability, in addition to its demonstrated suppression of T-cells and the induction of thymus involution through the elevation of plasma adrenal corticoids (16) (17) (18) , identifies the LDH-virus as a useful tool in the study of immunological competence and surveillance processes, and in the search for subtle infectious and physiological factors capable of modifying oncogenic and host processes. Because of the ubiquitous distribution of the LDH-virus, and its frequent contamination of mouse tumors and murine virus preparations, the hazard exists that spurious interpretations may be made from data obtained through experimental systems that unknowingly harbor this inconspicuous agent. Either direct or indirect effects of the virus may thus be erroneously assigned to the action of implanted tumors or to administered oncogenic viruses or other infectious agents (22, 23 (20) . The numbers in parentheses are the standard deviations. The differences induced by the virus are highly significant statistically (P < 0.001).
which can be measured with precision in the automatic amino acid analyzer (39, 40) .
Amino Acid Determinations. Amino acids were assayed with a Beckman model 120B amino acid analyzer, modified to provide accelerated, semi-automatic runs (39) . Improved methods of analysis were used (40) , with sodium citrate buffers for the basic amino acids and lithium citrate buffers for the acidic and neutral amino acids. The latter buffer system is essential for the satisfactory separation of asparagine, glutamine, and glutamic acid.
Protective Animal Facilities. The importance of using animal housing and handling techniques that minimize stress and prevent inadvertent contamination of mice used for immunological, viral, or cancer studies has been documented (6, (21) (22) (23) . Since experiments, such as those reported here, are undoubtedly sensitive to the physiological consequences of acute, chronic, or intermittent stress, use of appropriate animal holding facilities capable of controlling such undesirable disturbances are essential for obtaining reliable data. Such protective facilities have been briefly described (21, 24) . We used such stress-free facilities in all of the long-term experiments described in this report. This is significant because psychosocial and other forms of anxiety-induced stress cause rapid and significant increases in plasma corticosterone, which in turn causes involution and weight loss of the thymus, spleen, and lymph nodes, as well as a decrease in circulating thymus-dependent lymphocytes (T cells) (6, (16) (17) (18) . These physiological consequences of stressful stimuli have adverse influences on the immunological apparatus (25, 26) , and therefore should be adequately controlled, especially in studies that involve spleen antibody-producing cells, or related immunological cooperative Spleens from acutely infected mice (A) exhibited a 10-fold increase in numbers of AFC; in contrast, the later chronic viremia (B) suppressed the usual number of spleen AFC. The spleens were harvested and assayed under otherwise identical conditions for both the acute and chronic viremia. The acutely infected mice were inoculated with the virus 24 hr before sRBC injection; the chronically infected mice were infected 23 days before sRBC inoculation.
before intraperitoneal administration of the sRBC antigen. The LDH-virus reaches its peak titer of 1010 infectious units/ml of plasma by about 12 hr after the injection, and maintains this concentration for 72-96 hr. This period is designated as the "acute" phase (1) .
Splenomegaly. The data of Fig. 1 are expressed as the total number of AFC plaques per spleen, whereas the data in Table  1 are based on AFC per 108 spleen cells. It is appropriate to examine plaque production based upon both criteria, inasmuch as the LDH-viremia induces a mild splenomegaly (16) . It has been determined that the spleen enlargement is due to hyperplasia with an increase in the number of cells per spleen, but not in the number of cells per mg of spleen ( Table 2) .
Effect of Acute Viremia. The data of Table 1 reflect the results of a typical experiment showing the relative number of AFC activated by sRBC antigen only, compared with those of similar animals that were also injected with the LDH-virus at two separate time periods in relation to inoculation of the antigen; namely, both 24 hr before and at the same time as injection of the sRBC. In these experiments, the numbers of plaques or spleen antibody-producing cells were increased 3-to 64fold when the virus was injected 24 hr before the sRBC antigen. When the virus was injected simultaneously with the sRBC, the stimulation was somewhat less, ranging from 2.5 to 5.2 times that of the mice receiving sRBC only. The data of Table 1 also show a "nonspecific" production of AFC capable of reacting to sRBC when the LDH-virus was introduced, in the absence of sRBC, 72 hr before the spleens were harvested. Although the absolute numbers of AFC in both groups were smaller, the increase was nevertheless 4-to 6-fold over the numbers in untreated control animals. When the LDH-virus was injected 48 hr before spleen harvesting, no appreciable increase in AFC over those of the untreated controls was observed.
Influence of Virus on AFC Lag Period. Fig. 2 noninfected controls. By day 6, the number of AFC returned to a level considerably below that of the control spleens. It appears that chronic infection has a more profound long-term inhibitory influence on spleen AFC than the striking but ephemeral stimulation seen with acute infection, and thus, consequentially, on the long-term immunological competence of the host. Impainnent of Asparaginase Antibody. Although multiple forces are involved, a significant aspect of the LDH-virus potentiation of asparaginase therapy in mouse leukemia and lymphoma may be related to this immunological defect. It is the early appearance of asparaginase antibody that impairs the effectiveness of the therapeutic enzyme and thus permits the return of asparagine to the blood in noninfected mice. When this occurs, the asparagine-requiring malignancy regrows with lethal consequences. Fig. 3 reveals the delayed appearance of circulating asparaginase antibodies in infected mice treated with the enzyme. This delay is in contrast to the conventional appearance of neutralizing antibodies about 1 week after the initiation of asparaginase therapy in the absence of LDH-virus infection. The presence of neutralizing antibodies against asparaginase destroys the effectiveness of the enzyme therapy, which is indicated in Fig. 3 by the return to the plasma of the earlier depleted asparagine. This is followed by regrowth of the leukemia-lymphoma. Similar circumstances also occur with leukemia patients undergoing asparaginase therapy (14, 15, (41) (42) (43) . For a summary of additional physiological and biological effects of the LDH-virus that relate to immunological competence, see Table 3 .
Suppression of Asparaginase Antibodies by the LDH-Virus In Vivo. The data of Fig. 4 depict the behavior of administered asparaginase in the plasma of normal mice, as compared with those infected with the LDH-virus, during 14 days of asparaginase administration in which both groups of animals received the enzyme on a daily basis. The two curves are plots of the concentrations of asparaginase found in the blood plasma of the two experimental groups as a function of time.
After day 6, in the noninfected animals, despite a continued Proc. Natl. Acad. Sci. USA 73 (1976) (43) was not a significant factor at the dose levels used in the present studies.
Antibody Neutralization of Asparaginase In Vitro. In further support of the studies in vivo (Fig. 4) 24 hr before asparaginase administration. In order to compensate for the differences in enzyme clearance between normal and virus-infected animals (13), we adjusted the administered doses of enzyme to maintain approximately equal concentrations of enzyme in the circulating blood. Thus, the normal mice received 250 IU/kg per day, whereas the virus-infected mice required only 5 IU/kg per day. When virus-infected mice were given 250 IU/kg per day, the same shaped curve was obtained but it was displaced upwards. Each point on the curve represents the value of a plasma pool obtained from 10 mice.
The difference between the asparaginase levels during the experimental period from 8 to 15 days is highly significant statistically (P < 0.0005).
was obtained by micro double immunodiffusion with agarose gel. Precipitin lines were observed between asparaginase and plasma from noninfected mice at both 14 and 21 days after asparaginase injection, but were not seen in analogous virusinfected mice.
These and related observations that establish the changes in circulating asparaginase by direct quantitative measurements of the plasma of virus-infected and control animals will be reported separately (V. Riley (6, 45) . Corticosterone has an adverse influence upon the thymus, T cells, and macrophages, which compromises host cell-mediated immunity and T cell cooperative functions (6, 16, 17, 29) .
B Cell Stimulation and Inhibition. The third cell type affected by the virus is the antibody-forming B cell, which is stimulated for a brief period followed by a long-term suppression. Although it has been assumed that the B cells are impaired, the data only establish a suppression of their antibody-forming activities.
Influence of a Benign Virus on Malignant Processes. Other elements relevant to a complete analysis of this complex system may remain unrecognized. However, several of the factors that alter the immunological competence and surveillance capacities of the host as a consequence of this benign virus infection have been detected and characterized (1, 6, (16) (17) (18) 
